Related Experiment Videos
A comparison of patient compliance in treated vs untreated ocular hypertension
Insights
Many patients with asymptomatic high intraocular pressure (IOP) are lost to follow-up. Medical therapy improved compliance, but noncompliance remained high, necessitating better communication and recall systems.
Area of Science:
- Ophthalmology
- Public Health
Background:
- Asymptomatic elevations in intraocular pressure (IOP) pose a risk for vision loss.
- Patient adherence to follow-up evaluations is crucial for managing elevated IOP.
Purpose of the Study:
- To assess patient compliance with ophthalmic follow-up for newly diagnosed asymptomatic elevated intraocular pressure.
- To evaluate the impact of medical therapy on compliance.
- To identify strategies for improving management of noncompliant patients.
Main Methods:
- Prospective follow-up of 89 patients with newly diagnosed asymptomatic elevated IOP over 12-20 months.
- Comparison of compliance rates between patients receiving medical therapy and those not treated.
- Analysis of dropout rates and timing.
Main Results:
- 37% of patients were lost to follow-up, with most dropouts occurring within the first month.
- Medical therapy improved patient compliance compared to the untreated group.
- Noncompliance rates were high in both groups, despite treatment.
Conclusions:
- High rates of patient dropout and noncompliance are significant challenges in managing asymptomatic elevated IOP.
- Effective management requires enhanced physician-patient communication, patient education, and systematic reminder/recall systems.
Abstract:
Eighty-nine patients with newly diagnosed asymptomatic elevations of intraocular pressure were followed up over a 12- to 20-month interval. During this period 33 (37%) of the patients were lost to ophthalmic follow-up evaluation. The majority of these patients dropped out within one month following the initial diagnosis. While institution of medical therapy for the elevated ocular pressure improved patient compliance when compared to the nontreated group, the rates of noncompliance in both groups were unacceptably high in view of the disease risk. Management of the noncompliant patient requires good physician-patient communication, emphasis on patient education activities, and the use of selective reminder and recall systems within the ophthalmologist's office.